Custom distinctions in the interaction of G-protein β subunits with N-type (CaV2.2) versus P/Q-type (CaV2.1) calcium channels

被引:28
|
作者
Agler, HL
Evans, J
Colecraft, HM
Yue, DT
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Ca2 Signals Lab, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
来源
JOURNAL OF GENERAL PHYSIOLOGY | 2003年 / 121卷 / 06期
关键词
alpha(1A) and alpha(1B); channel modulation; voltage-dependent regulation; mathematical modeling; G proteins;
D O I
10.1085/jgp.200208770
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Inhibition of N-(Ca(v)2.2) and P/Q-type (Ca(v)2.1) calcium channels by G-proteins contribute importantly to presynaptic inhibition as well as to the effects of opiates and cannabinoids. Accordingly, elucidating the molecular mechanisms underlying G-protcin inhibition of voltage-gated calcium channels has been a major research focus. So far, inhibition is thought to result from the interaction of multiple propose sites with the Gbetagamma complex (Gbetagamma). Far less is known about the important interaction sites on Gbetagamma itself. Here, we developed a novel electrophysiological paradigm, "compound-state willing-reluctant analysis," to describe Gbetagamma interaction with Nand P/Q-type channels, and to provide a sensitive and efficient screen for changes in modulatory behavior over a broad range of potentials. The analysis confirmed that the apparent (un)binding kinetics of Gbetagamma with N-type are twofold slower than with P/Q-type at the voltage extremes, and emphasized that the kinetic discrepancy increases up to ten-fold in the mid-voltage range. To further investigate apparent differences in modulatory behavior, we screened both channels for the effects of single point alanine mutations within four regions of Gbeta(1), at residues known to interact with Galpha. These residues might thereby be expected to interact with channel effectors. Of eight mutations studied, six affected G-protein modulation of both N- and P/Q-type channels to varying degrees, and one had no appreciable effect on either channel. The remaining mutation was remarkable for selective attenuation of effects on P/Q-, but not N-type channels. Surprisingly, this mutation decreased the (un)binding rates without affecting its overall affinity. The latter mutation suggests that the binding surface on Gbetagamma for N- and P/Q-type channels are different. Also, the manner in which this last mutation affected P/Q-type channels suggests that some residues may be important for "steering" or guiding the protein into the binding pocket, whereas others are important for simply binding to the channel.
引用
收藏
页码:495 / 510
页数:16
相关论文
共 50 条
  • [41] Alternative splicing in the C-terminus of CaV2.2 controls expression and gating of N-type calcium channels
    Castiglioni, Andrew J.
    Raingo, Jesica
    Lipscombe, Diane
    JOURNAL OF PHYSIOLOGY-LONDON, 2006, 576 (01): : 119 - 134
  • [42] Deletion of the synaptic protein interaction site of the N-type (Cav2.2) calcium channel inhibits secretion in mouse pheochromocytoma cells
    Harkins, AB
    Cahill, AL
    Powers, JF
    Tischler, AS
    Fox, AP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (42) : 15219 - 15224
  • [43] CaV2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations
    Adams, Paul J.
    Garcia, Esperanza
    David, Laurence S.
    Mulatz, Kirk J.
    Spacey, Sian D.
    Snutch, Terrance P.
    CHANNELS, 2009, 3 (02) : 110 - 121
  • [44] A proteomic screen for presynaptic terminal N-type calcium channel (CaV2.2) binding partners
    Khanna, Rajesh
    Zougman, Alexandre
    Stanley, Elise F.
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 40 (03): : 302 - 314
  • [45] The separation of antagonist from agonist effects of trisubstituted purines on CaV2.2 (N-type) channels
    Buraei, Zafir
    Elmslie, Keith S.
    JOURNAL OF NEUROCHEMISTRY, 2008, 105 (04) : 1450 - 1461
  • [46] Clinical and molecular spectrum of P/Q type calcium channel Cav2.1 in epileptic patients
    Alehabib, Elham
    Esmaeilizadeh, Zahra
    Ranji-Burachaloo, Sakineh
    Tafakhori, Abbas
    Darvish, Hossein
    Movafagh, Abolfazl
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [47] A potent and selective indole N-type calcium channel (Cav2.2) blocker for the treatment of pain
    Tyagarajan, Sriram
    Chakravarty, Prasun K.
    Park, Min
    Zhou, Bishan
    Herrington, James B.
    Ratliff, Kevin
    Bugianesi, Randall M.
    Williams, Brande
    Haedo, Rodolfo J.
    Swensen, Andrew M.
    Warren, Vivien A.
    Smith, McHardy
    Garcia, Maria
    Kaczorowski, Gregory J.
    McManus, Owen B.
    Lyons, Kathryn A.
    Li, Xiaohua
    Madeira, Maria
    Karanam, Bindhu
    Green, Mitchell
    Forrest, Michael J.
    Abbadie, Catherine
    McGowan, Erin
    Mistry, Shruti
    Jochnowitz, Nina
    Duffy, Joseph L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 869 - 873
  • [48] Clinical and molecular spectrum of P/Q type calcium channel Cav2.1 in epileptic patients
    Elham Alehabib
    Zahra Esmaeilizadeh
    Sakineh Ranji-Burachaloo
    Abbas Tafakhori
    Hossein Darvish
    Abolfazl Movafagh
    Orphanet Journal of Rare Diseases, 16
  • [49] 1411-PosRoscovitine: a cdk5 inhibitor that slows deactivation of N-type (CaV2.2) calcium channels
    Buraei, Z
    Anghelescu, M
    Elmslie, KS
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 272A - 272A
  • [50] Binding of Gαo N terminus is responsible for the voltage-resistant inhibition of α1A(P/Q-type, Cav2.1) Ca2+ channels
    Kinoshita, M
    Nukada, T
    Asano, T
    Mori, Y
    Akaike, A
    Satoh, M
    Kaneko, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) : 28731 - 28738